research-abstracts.page.titleprefix
Review on the formulation and analysis of anti-diabetic agent : Gliclazide

Simple item page
dc.contributor.author A. B. M. Helal Uddin
dc.contributor.author Mohamed Alaama
dc.contributor.author Abdualrahman Mohammed Abdualkader
dc.contributor.author Mohamed B. Awang
dc.contributor.author Qamar Uddin Ahmed
dc.contributor.author Syed A. Abbas
dc.date.accessioned 2022-11-10T19:11:47Z
dc.date.available 2022-11-10T19:11:47Z
dc.date.copyright Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated
dc.date.issued 2013-00-00
dc.description Abstract : Gliclazide is a second generation sulfonylurea, which is used as antidiabetics drug. It is orally administrated and used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM)and has duration of action of 12 h or more. Beside its hypoglycaemic effects, gliclazide was reported to have many other important effects, such as: suppression of platelet functions, antithrombotic actions, decreased the production of tumour necrosis factor (TNF) α by endothelial cells and other effects. The unique activities of gliclazide has open a new avenue for the drug development research. This work is aimed to provide comprehensive information about gliclazide and its current research activities.
dc.description Full text access : Research & development Centre, Taylor’s University, Malaysia (e-mail: GTDLSRnD@taylors.edu.my)
dc.identifier.uri https://irepo.taylors.edu.my/handle/123456789/486
dc.subject Gliclazide
dc.subject Sulfonylureas
dc.title Review on the formulation and analysis of anti-diabetic agent : Gliclazide
dspace.entity.type Research-Abstracts
local.identifiers vital:642
local.identifiers valet-20140409-090051
local.language English
local.school School of Pharmacy
Files
Resources
Research Abstracts